Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...
The deal, disclosed on Wednesday 5 March, will see Jazz pay $8.55 per share, representing a 72.4% premium to Chimerix’s 4 ...
Several Pottsville parents testified during a termination hearing for a suspended athletic administrator that they did not ...
JNJ's $14B acquisition of ITCI bolsters its portfolio with Caplyta, showing strong sales and patent protection until 2033.
Four healthcare groups have filed an amicus brief in opposition to Johnson & Johnson's 340B rebate model, arguing the policy undermines federal law and threatens safety-net hospitals.
Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders.
Top surgical robotics experts say 2025 is going to be a really exciting year, with a particular eye on a quartet of companies ...
The seizure of these drugs is a direct result of the tireless work of our officers and partners,” Johnson said. “It’s another ...
Dr. Jay Bhattacharya is a health economist at Stanford University and was an outspoken critic of government COVID-19 ...
Lilly’s 1st DTC Ebglyss campaign highlights eczema’s effects on a range of skin tones and age groups
After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...
Congress did not reauthorize the rare pediatric disease priority review program at the end of 2024. Advocates say the ripple effect is already being felt across biopharma.
A New Haven federal grand jury returned an indictment Tuesday charging Terrance Johnson, 39, and Jordan Jamison, 29, with a fentanyl and cocaine trafficking offense.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback